S&P 500   4,587.85 (+0.47%)
DOW   35,836.49 (+0.27%)
QQQ   381.41 (+0.92%)
AAPL   150.70 (+1.39%)
MSFT   310.46 (+0.76%)
FB   328.10 (-0.18%)
GOOGL   2,797.82 (+1.78%)
TSLA   1,035.59 (+1.05%)
AMZN   3,403.35 (+2.50%)
NVDA   244.28 (+5.45%)
BABA   173.36 (-1.60%)
NIO   41.28 (+0.02%)
CGC   13.49 (-0.59%)
GE   108.22 (+2.77%)
AMD   124.83 (+2.02%)
MU   69.08 (+0.47%)
T   25.63 (-0.04%)
F   15.93 (-0.44%)
ACB   7.13 (-0.70%)
DIS   172.23 (+0.13%)
PFE   43.08 (-0.16%)
BA   213.48 (+0.29%)
AMC   36.81 (-0.05%)
S&P 500   4,587.85 (+0.47%)
DOW   35,836.49 (+0.27%)
QQQ   381.41 (+0.92%)
AAPL   150.70 (+1.39%)
MSFT   310.46 (+0.76%)
FB   328.10 (-0.18%)
GOOGL   2,797.82 (+1.78%)
TSLA   1,035.59 (+1.05%)
AMZN   3,403.35 (+2.50%)
NVDA   244.28 (+5.45%)
BABA   173.36 (-1.60%)
NIO   41.28 (+0.02%)
CGC   13.49 (-0.59%)
GE   108.22 (+2.77%)
AMD   124.83 (+2.02%)
MU   69.08 (+0.47%)
T   25.63 (-0.04%)
F   15.93 (-0.44%)
ACB   7.13 (-0.70%)
DIS   172.23 (+0.13%)
PFE   43.08 (-0.16%)
BA   213.48 (+0.29%)
AMC   36.81 (-0.05%)
S&P 500   4,587.85 (+0.47%)
DOW   35,836.49 (+0.27%)
QQQ   381.41 (+0.92%)
AAPL   150.70 (+1.39%)
MSFT   310.46 (+0.76%)
FB   328.10 (-0.18%)
GOOGL   2,797.82 (+1.78%)
TSLA   1,035.59 (+1.05%)
AMZN   3,403.35 (+2.50%)
NVDA   244.28 (+5.45%)
BABA   173.36 (-1.60%)
NIO   41.28 (+0.02%)
CGC   13.49 (-0.59%)
GE   108.22 (+2.77%)
AMD   124.83 (+2.02%)
MU   69.08 (+0.47%)
T   25.63 (-0.04%)
F   15.93 (-0.44%)
ACB   7.13 (-0.70%)
DIS   172.23 (+0.13%)
PFE   43.08 (-0.16%)
BA   213.48 (+0.29%)
AMC   36.81 (-0.05%)
S&P 500   4,587.85 (+0.47%)
DOW   35,836.49 (+0.27%)
QQQ   381.41 (+0.92%)
AAPL   150.70 (+1.39%)
MSFT   310.46 (+0.76%)
FB   328.10 (-0.18%)
GOOGL   2,797.82 (+1.78%)
TSLA   1,035.59 (+1.05%)
AMZN   3,403.35 (+2.50%)
NVDA   244.28 (+5.45%)
BABA   173.36 (-1.60%)
NIO   41.28 (+0.02%)
CGC   13.49 (-0.59%)
GE   108.22 (+2.77%)
AMD   124.83 (+2.02%)
MU   69.08 (+0.47%)
T   25.63 (-0.04%)
F   15.93 (-0.44%)
ACB   7.13 (-0.70%)
DIS   172.23 (+0.13%)
PFE   43.08 (-0.16%)
BA   213.48 (+0.29%)
AMC   36.81 (-0.05%)
CVE:GSD

Devonian Health Group Stock Forecast, Price & News

C$0.45
+0.05 (+12.50 %)
(As of 10/25/2021 03:47 PM ET)
Add
Compare
Today's Range
C$0.41
C$0.45
50-Day Range
C$0.31
C$0.49
52-Week Range
C$0.12
C$0.70
Volume8,000 shs
Average Volume35,568 shs
Market CapitalizationC$34.24 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive GSD News and Ratings via Email

Sign-up to receive the latest news and ratings for Devonian Health Group and its competitors with MarketBeat's FREE daily newsletter.


About Devonian Health Group

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, a Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric or duodenal ulcers; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, it acquires drug and health product licenses, as well as distributes pharmaceutical products. Devonian Health Group Inc. has a strategic alliance with CannTx Life Sciences Inc. for the development of cannabinoid-based pharmaceutical drugs. The company was incorporated in 2015 and is headquartered in Québec, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
C$1.46 million
Cash Flow
C$0.01 per share
Book Value
C$0.09 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
C$34.24 million
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.88 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Devonian Health Group (CVE:GSD) Frequently Asked Questions

What stocks does MarketBeat like better than Devonian Health Group?

Wall Street analysts have given Devonian Health Group a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Devonian Health Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Devonian Health Group's stock price been impacted by COVID-19?

Devonian Health Group's stock was trading at C$0.22 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, GSD shares have increased by 104.5% and is now trading at C$0.45.
View which stocks have been most impacted by COVID-19
.

Who are Devonian Health Group's key executives?

Devonian Health Group's management team includes the following people:
  • Dr. Andre P. Boulet, Chairman, Pres & CEO (Age 62, Pay $215.59k)
  • Ms. Colette Laurin C.A., CPA, Interim CFO & Corp. Controller
  • Mr. Tarique Saiyed, Sec. & Independent Director

What is Devonian Health Group's stock symbol?

Devonian Health Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "GSD."

How do I buy shares of Devonian Health Group?

Shares of GSD and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Devonian Health Group's stock price today?

One share of GSD stock can currently be purchased for approximately C$0.45.

How much money does Devonian Health Group make?

Devonian Health Group has a market capitalization of C$34.24 million and generates C$1.46 million in revenue each year.

What is Devonian Health Group's official website?

The official website for Devonian Health Group is www.groupedevonian.com.

How can I contact Devonian Health Group?

The company can be reached via phone at 450-937-6696.


This page was last updated on 10/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.